BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34953707)

  • 1. Hepatic tumours and radiotherapy.
    Rio E; Mornex F; Maingon P; Peiffert D; Parent L
    Cancer Radiother; 2022; 26(1-2):266-271. PubMed ID: 34953707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic tumors and radiotherapy].
    Rio E; Mornex F; Peiffert D; Huertas A
    Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External irradiation treatment process.
    Barillot I; Azria D; Lisbona A; Mahé MA
    Cancer Radiother; 2022; 26(1-2):20-28. PubMed ID: 34953717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
    Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
    Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organs at risk radiation dose constraints.
    Noël G; Antoni D
    Cancer Radiother; 2022; 26(1-2):59-75. PubMed ID: 34953713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung metastases radiation therapy.
    Lévy A; Darréon J; Mornex F; Giraud P; Thureau S
    Cancer Radiother; 2022; 26(1-2):244-249. PubMed ID: 34953714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stereotactic body radiation therapy in the management of liver tumours].
    Jacob J; Nguyen F; Deutsch E; Mornex F
    Cancer Radiother; 2014 Oct; 18(5-6):486-94. PubMed ID: 25195113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver].
    Debbi K; Janoray G; Scher N; Deutsch É; Mornex F
    Cancer Radiother; 2017 Oct; 21(6-7):604-612. PubMed ID: 28893525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External radiotherapy for prostatic cancers.
    de Crevoisier R; Supiot S; Créhange G; Pommier P; Latorzeff I; Chapet O; Pasquier D; Blanchard P; Schick U; Marchesi V; Sargos P; Hennequin C
    Cancer Radiother; 2022; 26(1-2):329-343. PubMed ID: 34955419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy of bone metastases.
    Thureau S; Supiot S; Jouglar E; Rogé M; Lebret L; Hadj Henni A; Beldjoudi G; Lagrange JL; Faivre JC
    Cancer Radiother; 2022; 26(1-2):368-376. PubMed ID: 34955420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-guided radiotherapy.
    de Crevoisier R; Lafond C; Mervoyer A; Hulot C; Jaksic N; Bessières I; Delpon G
    Cancer Radiother; 2022; 26(1-2):34-49. PubMed ID: 34953701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for primary lung cancer.
    Khalifa J; Lerouge D; Le Péchoux C; Pourel N; Darréon J; Mornex F; Giraud P
    Cancer Radiother; 2022; 26(1-2):231-243. PubMed ID: 34953709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy of lymphomas.
    Balosso J; Missohou F; Antoni D; Hennequin C; Mahé MA; Simon L; Demoor-Goldschmidt C
    Cancer Radiother; 2022; 26(1-2):388-396. PubMed ID: 34953716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of radiotherapy in the management of bladder cancer: Recommendations of the French society for radiation oncology.
    Fabiano E; Riou O; Pointreau Y; Périchon N; Durdux C
    Cancer Radiother; 2022; 26(1-2):315-322. PubMed ID: 34955411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of radiotherapy in the management of vulvar cancer: Recommendations of the French society for radiation oncology.
    Chargari C; Petit A; Escande A; Peignaux K; Lafond C; Peiffert D; Hannoun-Lévi JM; Durdux C; Haie-Méder C
    Cancer Radiother; 2022; 26(1-2):286-291. PubMed ID: 34953710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformal radiotherapy in management of soft tissue sarcoma in adults.
    Le Péchoux C; Llacer C; Sargos P; Moureau-Zabotto L; Ducassou A; Sunyach MP; Biston MC; Thariat J
    Cancer Radiother; 2022; 26(1-2):377-387. PubMed ID: 34961656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy of pancreatic cancers.
    Huguet F; Rivin Del Campo E; Orthuon A; Mornex F; Bessières I; Guimas V; Vendrely V
    Cancer Radiother; 2022; 26(1-2):259-265. PubMed ID: 34953706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy of cervical cancer.
    Chargari C; Peignaux K; Escande A; Renard S; Lafond C; Petit A; Lam Cham Kee D; Durdux C; Haie-Méder C
    Cancer Radiother; 2022; 26(1-2):298-308. PubMed ID: 34955418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereotactic body radiation therapy for hepatic malignancies: Organs at risk, uncertainties margins, doses].
    Lacornerie T; Rio E; Mahé MA
    Cancer Radiother; 2017 Oct; 21(6-7):574-579. PubMed ID: 28844506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: Case report of a complete pathological response and review of the literature].
    Pouëdras J; Izar F; Muscari F; Parent L; Breibach F; Péron JM; Otal P; Suc B; Rives M; Modesto A
    Cancer Radiother; 2018 Dec; 22(8):797-801. PubMed ID: 30523795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.